{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:01:09Z","timestamp":1789527669183,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","bmn.com","clinicalkey.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.tips.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:11:30Z","timestamp":1731589890000},"page":"1150-1161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Endometriosis: cannabidiol therapy for symptom relief"],"prefix":"10.1016","volume":"45","author":[{"given":"Lucy H.R.","family":"Whitaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-9380","authenticated-orcid":false,"given":"Philippa T.K.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2024.10.014_bb0005","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tips.2024.10.014_bb0010","article-title":"Pathophysiology, diagnosis, and management of endometriosis","volume":"379","author":"Horne","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2024.10.014_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2024.10.014_bb0020","article-title":"Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management","volume":"4","author":"Yang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tips.2024.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00439-023-02582-w","article-title":"Genomic characterisation of the overlap of endometriosis with 76 comorbidities identifies pleiotropic and causal mechanisms underlying disease risk","volume":"142","author":"McGrath","year":"2023","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tips.2024.10.014_bb0030","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/jog.15549","article-title":"New concepts on the etiology of endometriosis","volume":"49","author":"Cousins","year":"2023","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0035","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/humrep\/deae086","article-title":"Mullerian anomalies and endometriosis as potential explanatory models for the retrograde menstruation\/implantation and the embryonic remnants\/celomic metaplasia pathogenic theories: a systematic review and meta-analysis","volume":"39","author":"Vercellini","year":"2024","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tips.2024.10.014_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.rbmo.2019.10.007","article-title":"Pathogenesis of endometriosis: look no further than John Sampson","volume":"40","author":"Yovich","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.tips.2024.10.014_bb0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013776118","article-title":"Macrophages inhibit and enhance endometriosis depending on their origin","volume":"118","author":"Hogg","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2024.10.014_bb0050","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.fertnstert.2013.08.016","article-title":"Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis","volume":"100","author":"Rakhila","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tips.2024.10.014_bb0055","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.4081\/ejh.2024.4052","article-title":"CCL18 promotes endometriosis by increasing endometrial cell migration and neuroangiogenesis","volume":"68","author":"Peng","year":"2024","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.tips.2024.10.014_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpain.2015.09.008","article-title":"Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain","volume":"17","author":"As-Sanie","year":"2016","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/humupd\/dmu025","article-title":"Central changes associated with chronic pelvic pain and endometriosis","volume":"20","author":"Brawn","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.tips.2024.10.014_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.590823","article-title":"Pain in endometriosis","volume":"14","author":"Maddern","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.tips.2024.10.014_bb0075","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ACO.0000000000001305","article-title":"Endometriosis - a painful disease","volume":"36","author":"Coxon","year":"2023","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.tips.2024.10.014_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.medj.2023.02.006","article-title":"Endometriosis-associated chronic pelvic pain","volume":"4","author":"Karp","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.tips.2024.10.014_bb0085","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jpain.2023.03.004","article-title":"Association between nociplastic pain and pain severity and impact in women with chronic pelvic pain","volume":"24","author":"Till","year":"2023","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110370","article-title":"Genome-wide association reveals a locus in neuregulin 3 associated with gabapentin efficacy in women with chronic pelvic pain","volume":"27","author":"Mackenzie","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.tips.2024.10.014_bb0095","doi-asserted-by":"crossref","DOI":"10.1530\/RAF-23-0085","article-title":"The impact of the microbiota-gut-brain axis on endometriosis-associated symptoms: mechanisms and opportunities for personalised management strategies","volume":"5","author":"Hearn-Yeates","year":"2024","journal-title":"Reprod. Fertil."},{"key":"10.1016\/j.tips.2024.10.014_bb0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ajo.13642","article-title":"Cannabis for endometriosis-related pain and symptoms: It's high time that we see this as a legitimate treatment","volume":"63","author":"Armour","year":"2023","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.tips.2024.10.014_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12906-019-2431-x","article-title":"Self-management strategies amongst Australian women with endometriosis: a national online survey","volume":"19","author":"Armour","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.tips.2024.10.014_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/can.2021.0162","article-title":"Endometriosis and cannabis consumption during the COVID-19 pandemic: an international cross-sectional survey","volume":"7","author":"Armour","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/can.2021.0116","article-title":"Cannabis use for endometriosis: clinical and legal challenges in Australia and New Zealand","volume":"7","author":"Sinclair","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0120","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s00404-024-07652-6","article-title":"Cannabis use in endometriosis: the patients have their say-an online survey for German-speaking countries","volume":"310","author":"Jasinski","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.tips.2024.10.014_bb0125","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","article-title":"Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey","volume":"30","author":"Armour","year":"2021","journal-title":"J. Women's Health"},{"key":"10.1016\/j.tips.2024.10.014_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258940","article-title":"Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms","volume":"16","author":"Sinclair","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2024.10.014_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-21737-2_1","article-title":"Endocannabinoid system components: overview and tissue distribution","volume":"1162","author":"Joshi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tips.2024.10.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101999","article-title":"Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain","volume":"298","author":"Ghosh","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2024.10.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4323259","article-title":"Detection of Cannabinoid receptor expression by endometriotic lesions in women with endometriosis as an alternative to opioid-based pain medication","volume":"2022","author":"Allam","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tips.2024.10.014_bb0150","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules28165980","article-title":"Molecular and cellular mechanisms of action of cannabidiol","volume":"28","author":"Martinez Naya","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2024.10.014_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2021.726936","article-title":"Synthetic cannabinoid agonist WIN 55212-2 targets proliferation, angiogenesis, and apoptosis via MAPK\/AKT signaling in human endometriotic cell lines and a murine model of endometriosis","volume":"3","author":"Lingegowda","year":"2021","journal-title":"Front. Reprod. Health"},{"key":"10.1016\/j.tips.2024.10.014_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120582","article-title":"Pharmacological effects of cannabidiol by transient receptor potential channels","volume":"300","author":"Etemad","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2024.10.014_bb0165","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1210\/jc.2014-2282","article-title":"Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis","volume":"99","author":"Greaves","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2024.10.014_bb0170","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917705564","article-title":"Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosis","volume":"13","author":"Bohonyi","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0175","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/molecules28073271","article-title":"The polypharmacological effects of cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2024.10.014_bb0180","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1038\/s41598-022-13488-4","article-title":"Gene expression of the endocannabinoid system in endometrium through menstrual cycle","volume":"12","author":"Tanaka","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2024.10.014_bb0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00418-021-02018-4","article-title":"Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma","volume":"156","author":"Ayakannu","year":"2021","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.tips.2024.10.014_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.tips.2024.10.014_bb0195","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2024.10.014_bb0200","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1095\/biolreprod.110.084392","article-title":"Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy","volume":"83","author":"Novella-Maestre","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.tips.2024.10.014_bb0205","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/humrep\/deaa337","article-title":"Use of dopamine agonists to target angiogenesis in women with endometriosis","volume":"36","author":"Pellicer","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tips.2024.10.014_bb0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/biomedicines9030269","article-title":"A reassessment of the therapeutic potential of a dopamine receptor 2 agonist (D2-AG) in endometriosis by comparison against a standardized antiangiogenic treatment","volume":"9","author":"Tejada","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.tips.2024.10.014_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154771","article-title":"Cannabidiol goes nuclear: the role of PPARgamma","volume":"114","author":"Khosropoor","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tips.2024.10.014_bb0220","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1096\/fj.201900797R","article-title":"Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis","volume":"33","author":"Forster","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2024.10.014_bb0225","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/ph14060543","article-title":"PPARgamma agonists: emergent therapy in endometriosis","volume":"14","author":"Vallee","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2024.10.014_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107775","article-title":"Cannabinoid receptor 2 (CB2) modulators: a patent review (2016-2024)","volume":"153","author":"Naikoo","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.tips.2024.10.014_bb0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2024.10.014_bb0240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/pmt-2020-0110","article-title":"Cannabis-based medicines and pain: a review of potential synergistic and entourage effects","volume":"11","author":"Anand","year":"2021","journal-title":"Pain Manag."},{"key":"10.1016\/j.tips.2024.10.014_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.908198","article-title":"Medical cannabis activity against inflammation: active compounds and modes of action","volume":"13","author":"Anil","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2024.10.014_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clinthera.2023.03.007","article-title":"Medicinal cannabis guidance and resources for health professionals to inform clinical decision making","volume":"45","author":"Graham","year":"2023","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tips.2024.10.014_bb0255","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s40265-023-01951-z","article-title":"The place of cannabinoids in the treatment of gynecological pain","volume":"83","author":"Sinclair","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2024.10.014_bb0260","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2147\/IJGM.S275049","article-title":"Safety considerations in cannabinoid-based medicine","volume":"13","author":"Gottschling","year":"2020","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.tips.2024.10.014_bb0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000525629","article-title":"Perspectives on challenges in cannabis drug delivery systems: where are we?","volume":"5","author":"Palrasu","year":"2022","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.tips.2024.10.014_bb0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/ph13090219","article-title":"Towards better delivery of cannabidiol (CBD)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2024.10.014_bb0275","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","article-title":"Cannabinoid formulations and delivery systems: current and future options to treat pain","volume":"81","author":"Stella","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2024.10.014_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114390","article-title":"Building evidence on therapeutic efficacy and innovative mechanisms of cannabinoids in neurological disorders","volume":"364","author":"Reddy","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2024.10.014_bb0285","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ptr.7742","article-title":"Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids","volume":"37","author":"Reddy","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","article-title":"The therapeutic potential of purified cannabidiol","volume":"5","author":"O'Sullivan","year":"2023","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0295","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bcp.14038","article-title":"A systematic review of cannabidiol dosing in clinical populations","volume":"85","author":"Millar","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2024.10.014_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cts.13425","article-title":"The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence","volume":"16","author":"Arnold","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tips.2024.10.014_bb0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s42238-021-00073-1","article-title":"Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process","volume":"3","author":"Bhaskar","year":"2021","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0310","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1089\/can.2023.0025","article-title":"Pharmacokinetics of cannabidiol: a systematic review and meta-regression analysis","volume":"9","author":"Moazen-Zadeh","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0315","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcph.1412","article-title":"A Phase 1, open-label, parallel-group, single-dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment","volume":"59","author":"Taylor","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tips.2024.10.014_bb0320","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2174\/1570159X21666230322143401","article-title":"Update on cannabidiol clinical toxicity and adverse effects: a systematic review","volume":"21","author":"Madeo","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.tips.2024.10.014_bb0325","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/joim.13627","article-title":"Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis","volume":"293","author":"Lo","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tips.2024.10.014_bb0330","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10151","article-title":"Risk of adverse neonatal outcomes after combined prenatal cannabis and nicotine exposure","volume":"7","author":"Crosland","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tips.2024.10.014_bb0335","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/OGX.0000000000001159","article-title":"Cannabis and pregnancy: a review","volume":"78","author":"Hayer","year":"2023","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.tips.2024.10.014_bb0340","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.22.01632","article-title":"Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD)","volume":"41","author":"Hardy","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tips.2024.10.014_bb0345","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s13063-020-04541-6","volume":"21","author":"Hardy","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.tips.2024.10.014_bb0350","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.tips.2024.10.014_bb0355","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","article-title":"Results of a double-blind, randomized, placebo-controlled study of nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain","volume":"55","author":"Lichtman","year":"2018","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.tips.2024.10.014_bb0365","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/j.pain.0000000000002466","article-title":"Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial","volume":"163","author":"Vela","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0370","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071148","article-title":"Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial","volume":"13","author":"Lavender","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.tips.2024.10.014_bb0375","first-page":"1","article-title":"The safety and comparative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial","volume":"43","author":"Saleska","year":"2024","journal-title":"J. Am. Nutr. Assoc."},{"key":"10.1016\/j.tips.2024.10.014_bb0380","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/ph16081079","article-title":"Cannabis-based medicine for neuropathic pain and spasticity-a multicenter, randomized, double-blinded, placebo-controlled trial","volume":"16","author":"Hansen","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2024.10.014_bb0385","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/ph16020148","article-title":"Endocannabinoid system: chemical characteristics and biological activity","volume":"16","author":"Rezende","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2024.10.014_bb0390","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signalling in innate and adaptive immunity","volume":"144","author":"Chiurchiu","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.tips.2024.10.014_bb0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2013.12.042","article-title":"Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor","volume":"233","author":"Chiurchiu","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tips.2024.10.014_bb0400","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s42238-022-00163-8","article-title":"Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications","volume":"4","author":"Lingegowda","year":"2022","journal-title":"J. Cannabis Res."},{"key":"10.1016\/j.tips.2024.10.014_bb0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.beem.2018.03.004","article-title":"Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder","volume":"32","author":"Simitsidellis","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2024.10.014_bb0410","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-030-51856-1_6","article-title":"What have we learned from animal models of endometriosis and how can we use the knowledge gained to improve treatment of patients?","volume":"232","author":"Saunders","year":"2020","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.tips.2024.10.014_bb0415","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/j.pain.0000000000002248","article-title":"Preclinical models of endometriosis and interstitial cystitis\/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain","volume":"162","author":"Nunez-Badinez","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.tips.2024.10.014_bb0420","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50356","article-title":"Disease-modifying effects of natural Delta9-tetrahydrocannabinol in endometriosis-associated pain","volume":"9","author":"Escudero-Lara","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.tips.2024.10.014_bb0425","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96523","article-title":"Endocannabinoids and their receptors modulate endometriosis pathogenesis and immune response","volume":"13","author":"Lingegowda","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.tips.2024.10.014_bb0430","first-page":"175","article-title":"The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis","volume":"32","author":"Sanchez","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.tips.2024.10.014_bb0435","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jogc.2019.08.033","article-title":"Cannabis use, a self-management strategy among Australian women with endometriosis: results from a national online survey","volume":"42","author":"Sinclair","year":"2020","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.tips.2024.10.014_bb0440","article-title":"Current developments in endometriosis-associated pain","volume":"5","author":"Coxon","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614724002153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T16:06:58Z","timestamp":1733414818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614724002153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0165614724002153"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2024.10.014","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometriosis: cannabidiol therapy for symptom relief","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}